IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Kronox Lab Sciences IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 130.15 Cr. The company is based in Vadodara and caters to Chemical - Speciality sector. Pantomath Capital Advisors is the merchant banker of Kronox Lab Sciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th January 2024.
Kronox Lab Sciences IPO posted revenues of ₹ 90.25 Cr. and PAT of ₹ 20.63 Cr. in FY24 on annualised basis.
Revenue:
₹ 90.25 Cr.
EBITDA Margin:
30.23
% 
Net Worth: ₹ 60.28 Cr.
Market Capitalisation:
₹ 504.61 Cr.
P/E:
24.47 times
P/BV: 2.65 times
EV/EBITDA: 18.46 times
Financial results of Kronox Lab Sciences IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-23 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 66.96 | 54.03 | 56.79 | 37.64 | |
| Net Worth | 60.28 | 44.68 | 40.35 | 26.81 | |
| Total Debt | [●] | [●] | 0.64 | 0.01 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
67.69
90.25 |
95.58 | 82.25 | 62.46 | |
EBITDA
EBITDA on annualised basis |
20.46
27.28 |
22.00 | 19.70 | 14.80 | |
PAT
PAT on annualised basis |
15.47
20.63 |
16.62 | 13.63 | 9.73 | |
Kronox Lab Sciences IPO PAT Margin is 22.85 % , ROCE (Return on Capital Employed) is 33.15 % as per latest financial. The below table shows Kronox Lab Sciences IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-23 | FY23 | FY22 | FY21 |
|---|---|---|---|---|
| EBITDA Margin (%) | 30.23 | 23.02 | 23.95 | 23.70 |
| PAT Margin (%) | 22.85 | 17.39 | 16.57 | 15.58 |
| EPS (₹) | 4.17 | 4.30 | 3.49 | 2.40 |
| ROE (%) | 25.66 | 37.20 | 33.78 | 36.29 |
| ROCE (%) | 33.15 | 49.86 | 46.27 | 51.78 |
| ROA (%) | 23.10 | 30.76 | 24.00 | 25.85 |
| Debt to Equity | [●] | [●] | 0.02 | 0.00 |
The market Capitalisation of Kronox Lab Sciences IPO is ₹ 504.61 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Kronox Lab Sciences IPO prospectus highlights an Return on Equity (ROE) of 25.66 % , Return on Assets (ROA) of 23.10 %, and an EBITDA Margin of 30.23 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Kronox Lab Sciences IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Kronox Lab Sciences IPO is ₹ 504.61 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Kronox Lab Sciences IPO has a Price-to-Earnings (PE) ratio of 24.47 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Kronox Lab Sciences IPO reported revenue of ₹ 91.25 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Kronox Lab Sciences IPO provide insights into sales growth, market demand, and business scalability.
Kronox Lab Sciences recorded an EBITDA of ₹ 27.28 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Kronox Lab Sciences Profit After Tax (PAT) is ₹ 20.63 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 90.25 Cr.
EBITDA Margin:
30.23
%
Net Worth: ₹ 60.28 Cr.
Market Capitalisation:
504.61
P/E:
24.47 times
P/BV: 2.65 times
EV/EBITDA:
18.46
Kronox Lab Sciences operates in Chemical - Speciality and Chemical Speciality. The Issue is listed on BSE,NSE in Jun, 2024. Kronox Lab Sciences IPO size was 130.15 with Issue price of 136.00 .
Merchant Banker(s) of Kronox Lab Sciences IPO: Pantomath Capital Advisors Private Limited
Kronox Lab Sciences IPO subscription was 117.25 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Kronox Lab Sciences IPO listed at a listing price of 151.40 against the offer price of 136.00.
The current market price of Kronox Lab Sciences is 190.14.
Why Us?
